Click Here for 5% Off Your First Aladdin Purchase!

Reslizumab (anti-IL-5) - Primary antibody, specific to IL5, Human IgG4, INHIBITOR of Interleukin-5 inhibitor

  • Azide Free
  • Carrier Free
  • ExactAb™
  • Low Endotoxin
  • Recombinant
  • Validated
  • ≥95%(SDS-PAGE&SEC)
  • Lot by Lot
Features and benefits
  • Short Overview:

    Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

  • Species reactivity(Reacts with): Human
  • Isotype: Human IgG4
    Application:
  • Animal Model
  • ELISA
  • Flow Cytometry
  • Functional Assay
Item Number
Ab183026
Grouped product items
SKUSizeAvailabilityPrice Qty
Ab183026-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$159.90
Ab183026-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$799.90
Ab183026-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$1,999.90
Ab183026-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$3,199.90

Purity≥95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg; Human IgG4; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated

View related series
Accession#:P05113 Gene ID:3567 IL5

Basic Description

Product NameReslizumab (anti-IL-5) - Primary antibody, specific to IL5, Human IgG4
Specifications & PurityExactAb™, Validated, Carrier Free, Low Endotoxin, Azide Free, Recombinant, ≥95%(SDS-PAGE&SEC), Lot by Lot
SpecificityIL5
ConjugationUnconjugated
GradeAzide Free, Carrier Free, ExactAb™, Low Endotoxin, Recombinant, Validated
Action TypeINHIBITOR
Mechanism of actionINHIBITOR of Interleukin-5 inhibitor
Product Description

Reslizumab (anti-IL-5) is humanized monoclonal antibodies that target interleukin-5 (IL-5) for the treatment of eosinophilic asthma. Reslizumab (anti-IL-5) is effective in neutralizing the function of IL-5. Reslizumab (anti-IL-5) has high binding affinity for human IL-5, with KD values of 109 pM and 4.3 pM in the the Biacore surface plasmon resonance and Kinetic Exclusion Assay, respectively.
Purity
≥95% (SDS-PAGE&SEC)
Endotoxin Level
< 1.0EU/mg

Product Properties

IsotypeHuman IgG4
Light Chain Typekappa
Purification MethodProtein A purified
FormLiquid
ConcentrationLot by Lot
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -80℃ for 24 months. Upon delivery aliquot. Avoid freeze/thaw cycle.
CAS241473-69-8

Images

Reslizumab (anti-IL-5) (Ab183026) - ELISA
Immobilized hu-IL-5-His at 2.0 μg/mL can bind Reslizumab (anti-IL-5) (Ab183026) with the EC ₅₀ of 41.32 ng/mL.

Reslizumab (anti-IL-5) (Ab183026) - SEC
The purity of Reslizumab (anti-IL-5) (Ab183026) is more than 95% verified by HPLC.

Associated Targets

IL5 Tclin Interleukin-5 0 Activities

Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section

3 results found

Lot NumberCertificate TypeDateItem
ZJ24F0708696Certificate of AnalysisJul 24, 2024 Ab183026
ZJ24F0708695Certificate of AnalysisJul 24, 2024 Ab183026
ZJ24F0708694Certificate of AnalysisJul 24, 2024 Ab183026

Related Documents

Solution Calculators